Table 7.
Amount of permeated and accumulated BVZ after 24 h, expressed as a percentage, through the cornea, released from the ME systems under study.
Sample | % Diffused BVZ in 24 h | % Accumulated BVZ in 24 h |
---|---|---|
BVZ solution (Avastin®) | 0.40 ± 0.11 | 5.16 ± 0.66 |
M2 | 0.56 ± 0.09 | 15.24 ± 0.95 |
LC2 | 0.70 ± 0.11 | 19.89 ± 0.83 |
PL2 | 1.56 ± 0.09 | 4.08 ± 0.37 |